Article
The Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia.
Clinical lymphoma, myeloma & leukemia - 1 Jun 2022
Shafik Nevine F, Ibraheem Dalia, Selim Marwa Mahmoud, Allam Rasha Mahmoud, Fathalla Lamiaa A
Abstract excerpt
BACKGROUND: Many recurrent mutations are encountered in core binding factor acute myeloid leukemia (CBF-AML) which may affect the prognosis. Approximately 20 to 45% of CBF-AML patients have KIT mutations which are having poor prognosis and high incidence of relapse. There is still insufficient data to categorize the patients with c-kit mutation into which risk group and there is a debate around whether Tyrosine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
